熱門資訊> 正文

Regenxbio因新董事股票购买而上涨

2026-08-28 21:57

Regenxbio (RGNX) is up ~3% in Friday morning trading after recently appointed director Gregory Austin Ciongoli bought more than 102,000 shares valued at more than $949,000.
An SEC filing shows that he bought 49,196 shares on Aug. 26 at an average price of $9.14 and 53,407 shares on Aug. 27 at an average price of $9.36.
Ciongoli, the founder and managing partner of Adiumentum Capital Management, joined the board on Aug. 25.

More on Regenxbio

Regenxbio: Sell-Off On Hunter Setback Presents A Risky Buy Opportunity
Regenxbio's Multi-Catalyst Setup Is Hard To Ignore (Rating Upgrade)
REGENXBIO Inc. (RGNX) Q2 2026 Earnings Call Transcript
REGENXBIO sinks as FDA puts RGX-121 gene therapy on clinical hold
Regenxbio outlines cash runway into Q4 2027 as RGX-202 targets module 1 BLA filing in Q3 2026

推薦文章

風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。